Duo Xu

5PUBLICATIONS
12CO-AUTHORS
Epidemiological modellingMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 16, 2026
Distinct epidemiologic patterns of mesothelioma: evidence from a 16-year provincial cohort in China.

|Jul 24, 2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.

Duo Xu, Yanyun Gao, Shengchen Liu

|Dec 06, 2024
Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer.

Liang Zhao, Haibin Deng, Jingyi Zhang

|Jun 15, 2024
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.

Duo Xu, Shiyuan Yin, Yongqian Shu

Pageof 1

Frequent Collaborators

3 joint publications

Haibin Deng

3 joint publications

Ralph A Schmid

3 joint publications

Ren-Wang Peng

2 joint publications

Yongqian Shu